Personalis

About Personalis

Personalis Inc. is a provider of advanced cancer genomic testing and analytics solutions. The company offers liquid biopsy and tissue-based tests, such as NeXT Personal and ImmunoID NeXT, for detection of minimal residual disease, cancer recurrence, and comprehensive tumor profiling. These solutions support translational research, biomarker discovery, and the development of personalized cancer therapies. Personalis also provides whole exome and whole genome sequencing services for research and population genomics initiatives. Its customers include pharmaceutical and diagnostics companies, healthcare providers, research institutions, and patients.